After a dip in October, my Manulife MPF portfolio (“my MPF portfolio”) bounced back with a vengeance in November, delivering an impressive 3.05% return. Year-to-date, my portfolio has extended its upside to an impressive 17.78%, significantly outpacing the MPF Ratings MPF All Fund index's 9.72% return. Read on to discover the key to the outperformance and why I choose Calmar ratio to gauge risk-adjusted returns.

No rocket science here. Active management was the key reason behind the outperformance of my MPF portfolio. In November, Chinese equities remained lacklustre, while US equities saw strong gains following Donald Trump's victory in the presidential elections. A heavyweight position in the Manulife MPF North American Equity Fund, along with an underweight position in the Manulife MPF China Value Fund, were the main drivers behind the outperformance in November and the year-to-date outperformance.